The driving role of consortia on the critical path to innovative therapies View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-11

AUTHORS

Janet Woodcock, Martha Brumfield, Dalvir Gill, Elias Zerhouni

ABSTRACT

N/A

PAGES

781-781

Journal

TITLE

Nature Reviews Drug Discovery

ISSUE

11

VOLUME

13

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/nrd4462

DOI

http://dx.doi.org/10.1038/nrd4462

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1040808690

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25551158


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "author": [
      {
        "affiliation": {
          "alternateName": "Center for Drug Evaluation and Research", 
          "id": "https://www.grid.ac/institutes/grid.483500.a", 
          "name": [
            "Center for Drug Evaluation and Research, US Food and Drug Administration, Maryland, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Woodcock", 
        "givenName": "Janet", 
        "id": "sg:person.01107576476.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107576476.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "CEO of the Critical Path Institute, Arizona, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brumfield", 
        "givenName": "Martha", 
        "id": "sg:person.0617300464.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617300464.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "TransCelerate BioPharma, Pennsylvania, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gill", 
        "givenName": "Dalvir", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sanofi (France)", 
          "id": "https://www.grid.ac/institutes/grid.417924.d", 
          "name": [
            "Global Research & Development, Sanofi, Paris, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zerhouni", 
        "givenName": "Elias", 
        "id": "sg:person.0710152500.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0710152500.92"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2014-11", 
    "datePublishedReg": "2014-11-01", 
    "genre": "non_research_article", 
    "id": "sg:pub.10.1038/nrd4462", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1327423", 
        "issn": [
          "1474-1776", 
          "1474-1784"
        ], 
        "name": "Nature Reviews Drug Discovery", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "13"
      }
    ], 
    "name": "The driving role of consortia on the critical path to innovative therapies", 
    "pagination": "781-781", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "c265a49cadbf6a5f45d521191cfe0e546a0ae72a35c91bc0e661dcde798dbd3b"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25551158"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101124171"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/nrd4462"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1040808690"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/nrd4462", 
      "https://app.dimensions.ai/details/publication/pub.1040808690"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T16:29", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8669_00000425.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://www.nature.com/nrd/journal/v13/n11/full/nrd4462.html"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/nrd4462'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/nrd4462'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/nrd4462'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/nrd4462'


 

This table displays all metadata directly associated to this object as RDF triples.

87 TRIPLES      18 PREDICATES      26 URIs      20 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/nrd4462 schema:author Nb4dc69cc7cc84668bcd4d0ecd34089aa
2 schema:datePublished 2014-11
3 schema:datePublishedReg 2014-11-01
4 schema:genre non_research_article
5 schema:inLanguage en
6 schema:isAccessibleForFree false
7 schema:isPartOf N248c92b2dcf24725bf234cd6335788b2
8 N3fa3735fe3da44a6a749e8694a44de7f
9 sg:journal.1327423
10 schema:name The driving role of consortia on the critical path to innovative therapies
11 schema:pagination 781-781
12 schema:productId N0fb626dc69804812b5ff91cc121069c7
13 N1b650ee0dfdb4648b791ffd6aa01b2ab
14 N6570f7db3d2f4733a2411c16b4148372
15 N9dfd0ae4b16e4715940bb99e014d4d00
16 Ndd4eb0d9edf74c969922643528089376
17 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040808690
18 https://doi.org/10.1038/nrd4462
19 schema:sdDatePublished 2019-04-10T16:29
20 schema:sdLicense https://scigraph.springernature.com/explorer/license/
21 schema:sdPublisher Nb8573446973b44c4b430a23338645ac1
22 schema:url http://www.nature.com/nrd/journal/v13/n11/full/nrd4462.html
23 sgo:license sg:explorer/license/
24 sgo:sdDataset articles
25 rdf:type schema:ScholarlyArticle
26 N0fb626dc69804812b5ff91cc121069c7 schema:name dimensions_id
27 schema:value pub.1040808690
28 rdf:type schema:PropertyValue
29 N1b650ee0dfdb4648b791ffd6aa01b2ab schema:name readcube_id
30 schema:value c265a49cadbf6a5f45d521191cfe0e546a0ae72a35c91bc0e661dcde798dbd3b
31 rdf:type schema:PropertyValue
32 N1fd321cf9c8943729b4d30795674f672 schema:name CEO of the Critical Path Institute, Arizona, USA.
33 rdf:type schema:Organization
34 N248c92b2dcf24725bf234cd6335788b2 schema:issueNumber 11
35 rdf:type schema:PublicationIssue
36 N2b82b398102a4fb68cdce82084538806 rdf:first sg:person.0710152500.92
37 rdf:rest rdf:nil
38 N3fa3735fe3da44a6a749e8694a44de7f schema:volumeNumber 13
39 rdf:type schema:PublicationVolume
40 N6570f7db3d2f4733a2411c16b4148372 schema:name pubmed_id
41 schema:value 25551158
42 rdf:type schema:PropertyValue
43 N660e36eb0240437c9acc69a41a09220a schema:affiliation Nd1a40541bda64ae5904aa1d936379a59
44 schema:familyName Gill
45 schema:givenName Dalvir
46 rdf:type schema:Person
47 N8411196995ef45aebe3b6e1c150c39c4 rdf:first sg:person.0617300464.35
48 rdf:rest Nfa84df041c3242bbb30ba2ac3c52e06d
49 N9dfd0ae4b16e4715940bb99e014d4d00 schema:name doi
50 schema:value 10.1038/nrd4462
51 rdf:type schema:PropertyValue
52 Nb4dc69cc7cc84668bcd4d0ecd34089aa rdf:first sg:person.01107576476.16
53 rdf:rest N8411196995ef45aebe3b6e1c150c39c4
54 Nb8573446973b44c4b430a23338645ac1 schema:name Springer Nature - SN SciGraph project
55 rdf:type schema:Organization
56 Nd1a40541bda64ae5904aa1d936379a59 schema:name TransCelerate BioPharma, Pennsylvania, USA.
57 rdf:type schema:Organization
58 Ndd4eb0d9edf74c969922643528089376 schema:name nlm_unique_id
59 schema:value 101124171
60 rdf:type schema:PropertyValue
61 Nfa84df041c3242bbb30ba2ac3c52e06d rdf:first N660e36eb0240437c9acc69a41a09220a
62 rdf:rest N2b82b398102a4fb68cdce82084538806
63 sg:journal.1327423 schema:issn 1474-1776
64 1474-1784
65 schema:name Nature Reviews Drug Discovery
66 rdf:type schema:Periodical
67 sg:person.01107576476.16 schema:affiliation https://www.grid.ac/institutes/grid.483500.a
68 schema:familyName Woodcock
69 schema:givenName Janet
70 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107576476.16
71 rdf:type schema:Person
72 sg:person.0617300464.35 schema:affiliation N1fd321cf9c8943729b4d30795674f672
73 schema:familyName Brumfield
74 schema:givenName Martha
75 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617300464.35
76 rdf:type schema:Person
77 sg:person.0710152500.92 schema:affiliation https://www.grid.ac/institutes/grid.417924.d
78 schema:familyName Zerhouni
79 schema:givenName Elias
80 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0710152500.92
81 rdf:type schema:Person
82 https://www.grid.ac/institutes/grid.417924.d schema:alternateName Sanofi (France)
83 schema:name Global Research & Development, Sanofi, Paris, France.
84 rdf:type schema:Organization
85 https://www.grid.ac/institutes/grid.483500.a schema:alternateName Center for Drug Evaluation and Research
86 schema:name Center for Drug Evaluation and Research, US Food and Drug Administration, Maryland, USA.
87 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...